| Denumire comercială | DCI | Forma farmaceutică | Cod ATC | Cod CIM | Firma / țara deținătoare APP |  |
 |
 |
 |
 |
|
|---|---|---|---|---|---|---|---|---|---|---|---|
| KIMOKS 400 mg | MOXIFLOXACINUM | COMPR. FILM. | J01MA14 | W65324003 | ALKALOID-INT D.O.O. - SLOVENIA | ||||||
| KINERET 150mg/ml | ANAKINRA | SOL. INJ. IN SERINGA PREUMPLUTA | L04AC03 | W53719001 | SWEDISH ORPHAN BIOVITRUM AB (publ) - SUEDIA | X | |||||
| KINERET 150mg/ml | ANAKINRA | SOL. INJ. IN SERINGA PREUMPLUTA | L04AC03 | W53719002 | SWEDISH ORPHAN BIOVITRUM AB (publ) - SUEDIA | X | |||||
| KINERET 150mg/ml | ANAKINRA | SOL. INJ. IN SERINGA PREUMPLUTA | L04AC03 | W53719003 | SWEDISH ORPHAN BIOVITRUM AB (publ) - SUEDIA | X | |||||
| KINPARLEV 1 mg/24 h | ROTIGOTINUM | PLASTURE TRANSDERMIC | N04BC09 | W71937001 | ORION CORPORATION - FINLANDA | ||||||
| KINPARLEV 1 mg/24 h | ROTIGOTINUM | PLASTURE TRANSDERMIC | N04BC09 | W71937002 | ORION CORPORATION - FINLANDA | ||||||
| KINPARLEV 1 mg/24 h | ROTIGOTINUM | PLASTURE TRANSDERMIC | N04BC09 | W71937003 | ORION CORPORATION - FINLANDA | ||||||
| KINPARLEV 1 mg/24 h | ROTIGOTINUM | PLASTURE TRANSDERMIC | N04BC09 | W71937004 | ORION CORPORATION - FINLANDA | ||||||
| KINPARLEV 1 mg/24 h | ROTIGOTINUM | PLASTURE TRANSDERMIC | N04BC09 | W71937005 | ORION CORPORATION - FINLANDA | ||||||
| KINPARLEV 2 mg/24 h | ROTIGOTINUM | PLASTURE TRANSDERMIC | N04BC09 | W71938001 | ORION CORPORATION - FINLANDA | ||||||
| KINPARLEV 2 mg/24 h | ROTIGOTINUM | PLASTURE TRANSDERMIC | N04BC09 | W71938002 | ORION CORPORATION - FINLANDA | ||||||
| KINPARLEV 2 mg/24 h | ROTIGOTINUM | PLASTURE TRANSDERMIC | N04BC09 | W71938003 | ORION CORPORATION - FINLANDA | ||||||
| KINPARLEV 2 mg/24 h | ROTIGOTINUM | PLASTURE TRANSDERMIC | N04BC09 | W71938004 | ORION CORPORATION - FINLANDA | ||||||
| KINPARLEV 2 mg/24 h | ROTIGOTINUM | PLASTURE TRANSDERMIC | N04BC09 | W71938005 | ORION CORPORATION - FINLANDA | ||||||
| KINPARLEV 3 mg/24 h | ROTIGOTINUM | PLASTURE TRANSDERMIC | N04BC09 | W71939001 | ORION CORPORATION - FINLANDA | ||||||
| KINPARLEV 3 mg/24 h | ROTIGOTINUM | PLASTURE TRANSDERMIC | N04BC09 | W71939002 | ORION CORPORATION - FINLANDA | ||||||
| KINPARLEV 3 mg/24 h | ROTIGOTINUM | PLASTURE TRANSDERMIC | N04BC09 | W71939003 | ORION CORPORATION - FINLANDA | ||||||
| KINPARLEV 3 mg/24 h | ROTIGOTINUM | PLASTURE TRANSDERMIC | N04BC09 | W71939004 | ORION CORPORATION - FINLANDA | ||||||
| KINPARLEV 3 mg/24 h | ROTIGOTINUM | PLASTURE TRANSDERMIC | N04BC09 | W71939005 | ORION CORPORATION - FINLANDA | ||||||
| KINPARLEV 4 mg/24 h | ROTIGOTINUM | PLASTURE TRANSDERMIC | N04BC09 | W71940001 | ORION CORPORATION - FINLANDA |
ANMDMR - Nomenclatorul medicamentelor pentru uz uman